Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Harrison

Showing results (71-80 of 174) with videos related to

Pageof 18
Sort By:
Open Forum Infectious Diseases|July 7, 2022
Prior Pulmonary Tuberculosis Is a Risk Factor for Asymptomatic Cryptococcal Antigenemia in a Cohort of Adults With Advanced Human Immunodeficiency Virus DiseaseRachel M Wake, Nazir A Ismail, Shaheed V Omar, et al.
Plos Neglected Tropical Diseases|February 21, 2025
A composite subunit vaccine confers full protection against Buruli ulcer disease in the mouse footpad model of Mycobacterium ulcerans infectionJustice Kofi Boakye-Appiah, Andy C Tran, Matthew J Paul, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2006
Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitisAnnemarie E Brouwer, Hendrikus J M van Kan, Elizabeth Johnson, et al.
The Journal of Infection|November 15, 2011
Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitisConrad K Muzoora, Taseera Kabanda, Giuseppina Ortu, et al.
AIDS (London, England)|March 17, 2012
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trialJoseph N Jarvis, Graeme Meintjes, Kevin Rebe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2015
Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort StudyNicky Longley, Joseph Nicholas Jarvis, Graeme Meintjes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2022
How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?Thomas S Harrison, David S Lawrence, Henry C Mwandumba, et al.
British Journal of Clinical Pharmacology|July 14, 2020
Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trialsEmma H Baker, Kamal Patel, Jonathan Ball, et al.
Journal of Medical Case Reports|April 6, 2023
Presacral malakoplakia presenting as foot drop: a case reportTom A Yates, Katie Devlin, Abed Arnaout, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2014
Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitisJoseph N Jarvis, Tihana Bicanic, Angela Loyse, et al.
Pageof 18

Showing results (71-80 of 174) with videos related to

Sort By:
Pageof 18
Open Forum Infectious Diseases|July 7, 2022
Prior Pulmonary Tuberculosis Is a Risk Factor for Asymptomatic Cryptococcal Antigenemia in a Cohort of Adults With Advanced Human Immunodeficiency Virus DiseaseRachel M Wake, Nazir A Ismail, Shaheed V Omar, et al.
Plos Neglected Tropical Diseases|February 21, 2025
A composite subunit vaccine confers full protection against Buruli ulcer disease in the mouse footpad model of Mycobacterium ulcerans infectionJustice Kofi Boakye-Appiah, Andy C Tran, Matthew J Paul, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2006
Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitisAnnemarie E Brouwer, Hendrikus J M van Kan, Elizabeth Johnson, et al.
The Journal of Infection|November 15, 2011
Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitisConrad K Muzoora, Taseera Kabanda, Giuseppina Ortu, et al.
AIDS (London, England)|March 17, 2012
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trialJoseph N Jarvis, Graeme Meintjes, Kevin Rebe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2015
Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort StudyNicky Longley, Joseph Nicholas Jarvis, Graeme Meintjes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2022
How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?Thomas S Harrison, David S Lawrence, Henry C Mwandumba, et al.
British Journal of Clinical Pharmacology|July 14, 2020
Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trialsEmma H Baker, Kamal Patel, Jonathan Ball, et al.
Journal of Medical Case Reports|April 6, 2023
Presacral malakoplakia presenting as foot drop: a case reportTom A Yates, Katie Devlin, Abed Arnaout, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2014
Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitisJoseph N Jarvis, Tihana Bicanic, Angela Loyse, et al.
Pageof 18